The role of CARDPC in response to COVID-19 in primary care in China
Authors:
Open Access
- 18 September 2020
- journal article
- research article
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 30 (1) , 1-4
Abstract
COVID-19 is wreaking havoc around the world, which is a serious challenge to all our health systems. China reacted quickly in the early stage of the pandemic, and accumulated a lot of experiences, especially in the prevention and control of COVID-19 at the primary care level. Here, we would like to share how the Chinese Alliance for Respiratory Diseases in Primary Care (CARDPC) played a role in the pandemic, hoping to provide guidance and hope for effective control of the outbreak worldwide, for future public health emergencies and for systematic management of chronic respiratory diseases in the community.Keywords
This publication has 5 references indexed in Scilit:
- Strategies for the prevention and management of coronavirus disease 2019European Respiratory Journal, 2020
- Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysisEuropean Respiratory Journal, 2020
- Prevalence, risk factors, and management of asthma in China: a national cross-sectional studyThe Lancet, 2019
- Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional studyThe Lancet, 2018
- The primary health-care system in ChinaThe Lancet, 2017